Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein Levels
Top Cited Papers
- 1 July 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 60 (7) , 958-964
- https://doi.org/10.1001/archneur.60.7.958
Abstract
Research from JAMA Neurology — Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein LevelsKeywords
This publication has 6 references indexed in Scilit:
- APPENDIX C: PRACTICE PARAMETER: EARLY DETECTION OF DEMENTIA: MILD COGNITIVE IMPAIRMENT (AN EVIDENCE-BASED REVIEW)CONTINUUM: Lifelong Learning in Neurology, 2007
- Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptideNeurology, 2002
- A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activityNature, 2001
- Alzheimer disease therapeutics.Journal of Neuropathology and Experimental Neurology, 2001
- High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E GenotypeArchives of Neurology, 1998
- The Clinical Dementia Rating (CDR)Neurology, 1993